Amino acid amides of phenoxybutyric acid derivatives
OwnerIraj Lalezari, Jill Fabricantinventors
Life of this patent
Estimating the term…
Abstract
A compound of the formula: where X is phenyl substituted at the 3, 4 and 5 positions with R1, R2 or R3 which are selected from hydrogen, chloro, lower alkyl of 1 to 5 carbons, phenoxy, phenyl, naphthyl, or phenyl (lower) alkyl where the lower alkyl group has 1-5 carbon atoms and m is 0 or 1; Y is —CONH— or —NHCONH— where the nitrogen atoms are unsubstituted or substituted with other phenoxyisobutyric acid derivatives, or the residue of a phenoxyisobutyric acid and n is 0 or 1; Z is unsubstituted phenyl when m is 1 and n is 1; when Y is 0, X is 0; Z is also substituted.
Claims21
A compound of the formula:
- where X is phenyl substituted at the 3, 4 and 5 positions with R1, R2 or R3 which are selected from hydrogen, chloro, lower alkyl of 1 to 5 carbons, phenoxy, phenyl, naphthyl, or phenyl (lower) alkyl where the lower alkyl group has 1-5 carbon atoms and m is 0 or 1;
- Y is —CONH— or —NHCONH— where the nitrogen atoms are unsubstituted or substituted with other phenoxyisobutyric acid derivatives, or the residue of a phenoxyisobutyric acid and n is 0 or 1;
- Z is unsubstituted phenyl when m is 1 and n is 1;
- when Y is 0, X is 0;
- Z is phenyl substituted at the 3, 4 and 5 positions with R1, R2 or R3 which are selected from hydrogen, chloro, lower alkyl of 1 to 5 carbons, phenoxy, phenyl, naphthyl, or phenyl (lower) alkyl where the lower alkyl group has 1-5 carbon atoms;
- and R4 is hydrogen;
- alkyl of 1-5 carbon atoms;
- aminoalkyl COOR5, where the alkyl group may be substituted with a carboxyl or histidine substituted lower alkyl group having 1-5 carbons and, or is a cycloalkyl group;
- R5 is hydrogen or lower alkyl of 1-5 carbons or an acyl-lower alkyl group where the lower alkyl group has 1-5 carbons.
(canceled)
A method of preventing the formation of advanced glycation end products or breaking advanced glycation end products which comprises administering an amount of a compound of formula (I), to a patient who may form or has formed advanced glycation end products, which is effective to prevent or break said glycation end products.
A method of treating a condition selected from the group consisting of chronic inflammation, neuropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction and diabetes which comprises administering to a patient having a condition selected from the group consisting of chronic inflammation, neuropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction, pre-diabetes and diabetes, an amount of a compound selected from formula (I) which is effective to treat said condition.
21-29. (canceled)
Dependencies are inferred from the claim text.